Naproxen Sodium Tablet, Film Coated, Extended Release
Product Images NDC 0480-0953

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Naproxen Sodium (NDC 0480-0953). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Naproxen sodium is a chemical compound with the molecular formula C14H13NaO3 and a molecular weight of 252.24. The other texts do not provide any useful information and seem to be arbitrary chemical symbols.*

FDA Label Image

1 (Image 2)

This appears to be a prescription for Naproxen, an NSAID (Non-Steroidal Anti-Inflammatory Drug), with dosage instructions to take 500mg every 12 hours. The second line mentions Naproxen Sodium in extended-release form, with a dosage of 1000mg to be taken every 24 hours. The rest of the text seems to be some kind of chart or table with measurements in "mg/mL" and a time scale in hours, but without more context or information it is difficult to provide a specific description of what the chart is showing.*

FDA Label Image

1 (Image 3)

This is a description of a medication containing Naproxen Sodium (a nonsteroidal anti-inflammatory drug) with extended-release tablets. The medication comes in a container with 100 tablets. A medication guide should be given to each patient by the pharmacist. The usual dosage is to be followed as described in the accompanying information. The tablets should be stored in a well-closed container at 20 to 25°C. The manufacturing company is Watson Pharma Private Limited based in India. There is a serialization coding area in the label.*

FDA Label Image

1 (Image 4)

This is a medication, which is Naproxen Sodium, available in an extended-release tablet form. It comes in a bottle of 75 tablets and each tablet contains 500 mg Naproxen. A medication guide should be provided to each patient by the pharmacist. The usual dosage is recommended to be followed. Store the medicine in a tightly closed container and at a controlled room temperature. The medication is licensed by Mg Lic.No. 741 and manufactured by Watsan Pharma Private Limited, India, for Teva Pharmaceuticals, Parsippany, NJ. The code for serialization is 0480-0952-55.*

FDA Label Image

1 (Image 5)

This is the description for a medication packet of Naproxen Sodium and Quinine. The packet contains 30 extended-release tablets with each tablet containing 825g of the medication. The usual dosage is specified in the package insert. The tablets should be stored at a temperature of 20 - 25 degrees Celsius. The manufacturer of the medication is Watson Pharma Private Limited under the serialization coding area. There is also a reference to Teva Pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.